Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Association of peripheral inflammatory markers with connectivity in large-scale functional brain networks of non-demented older adults.

Walker KA, Gross AL, Moghekar AR, Soldan A, Pettigrew C, Hou X, Lu H, Alfini AJ, Bilgel M, Miller MI, Albert MS, Walston J.

Brain Behav Immun. 2020 Jan 11. pii: S0889-1591(19)31061-X. doi: 10.1016/j.bbi.2020.01.006. [Epub ahead of print]

PMID:
31935468
2.

Cognitive reserve and rate of change in Alzheimer's and cerebrovascular disease biomarkers among cognitively normal individuals.

Pettigrew C, Soldan A, Zhu Y, Cai Q, Wang MC, Moghekar A, Miller MI, Singh B, Martinez O, Fletcher E, DeCarli C, Albert M.

Neurobiol Aging. 2019 Dec 17. pii: S0197-4580(19)30431-2. doi: 10.1016/j.neurobiolaging.2019.12.003. [Epub ahead of print]

PMID:
31932050
3.

White matter hyperintensities and CSF Alzheimer disease biomarkers in preclinical Alzheimer disease.

Soldan A, Pettigrew C, Zhu Y, Wang MC, Moghekar A, Gottesman RF, Singh B, Martinez O, Fletcher E, DeCarli C, Albert M; BIOCARD Research Team.

Neurology. 2019 Dec 30. pii: 10.1212/WNL.0000000000008864. doi: 10.1212/WNL.0000000000008864. [Epub ahead of print]

PMID:
31888969
4.

Medial temporal lobe white matter pathway variability is associated with individual differences in episodic memory in cognitively normal older adults.

Alm KH, Faria AV, Moghekar A, Pettigrew C, Soldan A, Mori S, Albert M, Bakker A.

Neurobiol Aging. 2019 Nov 21. pii: S0197-4580(19)30410-5. doi: 10.1016/j.neurobiolaging.2019.11.011. [Epub ahead of print]

PMID:
31874745
5.

Plasma Markers of Inflammation Linked to Clinical Progression and Decline During Preclinical AD.

Gross AL, Walker KA, Moghekar AR, Pettigrew C, Soldan A, Albert MS, Walston JD.

Front Aging Neurosci. 2019 Sep 6;11:229. doi: 10.3389/fnagi.2019.00229. eCollection 2019.

6.

On-farm inspections of fractious animals.

Clark J, Soldan A.

Vet Rec. 2019 Sep 21;185(11):347. doi: 10.1136/vr.l5593. No abstract available.

PMID:
31541053
7.

A harmonized longitudinal biomarkers and cognition database for assessing the natural history of preclinical Alzheimer's disease from young adulthood and for designing prevention trials.

Xiong C, Luo J, Agboola F, Li Y, Albert M, Johnson SC, Koscik RL, Masters CL, Soldan A, Villemagne VL, Li QX, McDade EM, Fagan AM, Massoumzadeh P, Benzinger T, Hassenstab J, Bateman RJ, Morris JC; Dominantly Inherited Alzheimer Network.

Alzheimers Dement. 2019 Nov;15(11):1448-1457. doi: 10.1016/j.jalz.2019.06.4955. Epub 2019 Sep 7.

PMID:
31506247
8.

Resting-State Functional Connectivity Is Associated With Cerebrospinal Fluid Levels of the Synaptic Protein NPTX2 in Non-demented Older Adults.

Soldan A, Moghekar A, Walker KA, Pettigrew C, Hou X, Lu H, Miller MI, Alfini A, Albert M, Xu D, Xiao MF, Worley P; BIOCARD Research Team.

Front Aging Neurosci. 2019 Jun 7;11:132. doi: 10.3389/fnagi.2019.00132. eCollection 2019.

9.

Precision Aging: Applying Precision Medicine to the Field of Cognitive Aging.

Ryan L, Hay M, Huentelman MJ, Duarte A, Rundek T, Levin B, Soldan A, Pettigrew C, Mehl MR, Barnes CA.

Front Aging Neurosci. 2019 Jun 7;11:128. doi: 10.3389/fnagi.2019.00128. eCollection 2019.

10.

Brain Oxygen Extraction by Using MRI in Older Individuals: Relationship to Apolipoprotein E Genotype and Amyloid Burden.

Lin Z, Sur S, Soldan A, Pettigrew C, Miller M, Oishi K, Bilgel M, Moghekar A, Pillai JJ, Albert M, Lu H.

Radiology. 2019 Jul;292(1):140-148. doi: 10.1148/radiol.2019182726. Epub 2019 Apr 23.

11.

Identifying Changepoints in Biomarkers During the Preclinical Phase of Alzheimer's Disease.

Younes L, Albert M, Moghekar A, Soldan A, Pettigrew C, Miller MI.

Front Aging Neurosci. 2019 Apr 2;11:74. doi: 10.3389/fnagi.2019.00074. eCollection 2019.

12.

Multi-atlas based detection and localization (MADL) for location-dependent quantification of white matter hyperintensities.

Wu D, Albert M, Soldan A, Pettigrew C, Oishi K, Tomogane Y, Ye C, Ma T, Miller MI, Mori S.

Neuroimage Clin. 2019;22:101772. doi: 10.1016/j.nicl.2019.101772. Epub 2019 Mar 13.

13.

ATN profiles among cognitively normal individuals and longitudinal cognitive outcomes.

Soldan A, Pettigrew C, Fagan AM, Schindler SE, Moghekar A, Fowler C, Li QX, Collins SJ, Carlsson C, Asthana S, Masters CL, Johnson S, Morris JC, Albert M, Gross AL.

Neurology. 2019 Apr 2;92(14):e1567-e1579. doi: 10.1212/WNL.0000000000007248. Epub 2019 Mar 6.

PMID:
30842300
14.

Mechanisms underlying resilience in ageing.

Stern Y, Chételat G, Habeck C, Arenaza-Urquijo EM, Vemuri P, Estanga A, Bartrés-Faz D, Cantillon M, Clouston SAP, Elman JA, Gold BT, Jones R, Kempermann G, Lim YY, van Loenhoud A, Martínez-Lage P, Morbelli S, Okonkwo O, Ossenkoppele R, Pettigrew C, Rosen AC, Scarmeas N, Soldan A, Udeh-Momoh C, Valenzuela M, Vuoksimaa E.

Nat Rev Neurosci. 2019 Apr;20(4):246. doi: 10.1038/s41583-019-0138-0. No abstract available.

PMID:
30814677
15.

Defining Cognitive Reserve and Implications for Cognitive Aging.

Pettigrew C, Soldan A.

Curr Neurol Neurosci Rep. 2019 Jan 9;19(1):1. doi: 10.1007/s11910-019-0917-z. Review.

PMID:
30627880
16.

Alternative multi-dose TB testing gun.

Soldan A.

Vet Rec. 2018 Nov 3;183(17):538. doi: 10.1136/vr.k4566. No abstract available.

PMID:
30389875
17.

Self-reported Lifestyle Activities in Relation to Longitudinal Cognitive Trajectories.

Pettigrew C, Shao Y, Zhu Y, Grega M, Brichko R, Wang MC, Carlson MC, Albert M, Soldan A.

Alzheimer Dis Assoc Disord. 2019 Jan-Mar;33(1):21-28. doi: 10.1097/WAD.0000000000000281.

18.

Depressive symptoms in relation to clinical symptom onset of mild cognitive impairment.

Chan CK, Soldan A, Pettigrew C, Wang MC, Wang J, Albert MS, Rosenberg PB; BIOCARD Research Team.

Int Psychogeriatr. 2019 Apr;31(4):561-569. doi: 10.1017/S1041610218001138. Epub 2018 Oct 10.

19.

Whitepaper: Defining and investigating cognitive reserve, brain reserve, and brain maintenance.

Stern Y, Arenaza-Urquijo EM, Bartrés-Faz D, Belleville S, Cantilon M, Chetelat G, Ewers M, Franzmeier N, Kempermann G, Kremen WS, Okonkwo O, Scarmeas N, Soldan A, Udeh-Momoh C, Valenzuela M, Vemuri P, Vuoksimaa E; Reserve, Resilience and Protective Factors PIA Empirical Definitions and Conceptual Frameworks Workgroup.

Alzheimers Dement. 2018 Sep 14. pii: S1552-5260(18)33491-5. doi: 10.1016/j.jalz.2018.07.219. [Epub ahead of print] Review.

PMID:
30222945
20.

Technological advances in veterinary diagnostics: opportunities to deploy rapid decentralised tests to detect pathogens affecting livestock.

Howson ELA, Soldan A, Webster K, Beer M, Zientara S, Belák S, Sanchez-Vizcaino JM, Van Borm S, King DP, Fowler VL.

Rev Sci Tech. 2017 Aug;36(2):479-498. doi: 10.20506/rst.36.2.2668.

21.

Combined neuropathological pathways account for age-related risk of dementia.

Power MC, Mormino E, Soldan A, James BD, Yu L, Armstrong NM, Bangen KJ, Delano-Wood L, Lamar M, Lim YY, Nudelman K, Zahodne L, Gross AL, Mungas D, Widaman KF, Schneider J.

Ann Neurol. 2018 Jul;84(1):10-22. doi: 10.1002/ana.25246. Epub 2018 Jun 26.

22.

Evaluating Cognitive Reserve Through the Prism of Preclinical Alzheimer Disease.

Soldan A, Pettigrew C, Albert M.

Psychiatr Clin North Am. 2018 Mar;41(1):65-77. doi: 10.1016/j.psc.2017.10.006. Epub 2017 Dec 7. Review.

23.

Predicting progression from normal cognition to mild cognitive impairment for individuals at 5 years.

Albert M, Zhu Y, Moghekar A, Mori S, Miller MI, Soldan A, Pettigrew C, Selnes O, Li S, Wang MC.

Brain. 2018 Mar 1;141(3):877-887. doi: 10.1093/brain/awx365.

24.

Cognitive reserve and long-term change in cognition in aging and preclinical Alzheimer's disease.

Soldan A, Pettigrew C, Cai Q, Wang J, Wang MC, Moghekar A, Miller MI, Albert M; BIOCARD Research Team.

Neurobiol Aging. 2017 Dec;60:164-172. doi: 10.1016/j.neurobiolaging.2017.09.002. Epub 2017 Sep 11.

25.

Progressive medial temporal lobe atrophy during preclinical Alzheimer's disease.

Pettigrew C, Soldan A, Sloane K, Cai Q, Wang J, Wang MC, Moghekar A, Miller MI, Albert M; BIOCARD Research Team.

Neuroimage Clin. 2017 Aug 25;16:439-446. doi: 10.1016/j.nicl.2017.08.022. eCollection 2017.

26.

A classification algorithm for predicting progression from normal cognition to mild cognitive impairment across five cohorts: The preclinical AD consortium.

Gross AL, Hassenstab JJ, Johnson SC, Clark LR, Resnick SM, Kitner-Triolo M, Masters CL, Maruff P, Morris JC, Soldan A, Pettigrew C, Albert MS.

Alzheimers Dement (Amst). 2017 May 30;8:147-155. doi: 10.1016/j.dadm.2017.05.003. eCollection 2017.

27.

The BIOCARD Index: A Summary Measure to Predict Onset of Mild Cognitive Impairment.

Sacktor N, Soldan A, Grega M, Farrington L, Cai Q, Wang MC, Gottesman RF, Turner RS, Albert M; BIOCARD Research Team.

Alzheimer Dis Assoc Disord. 2017 Apr-Jun;31(2):114-119. doi: 10.1097/WAD.0000000000000194.

28.

Computerized Cognitive Tests Are Associated with Biomarkers of Alzheimer's Disease in Cognitively Normal Individuals 10 Years Prior.

Soldan A, Pettigrew C, Moghekar A, Albert M; BIOCARD Research Team.

J Int Neuropsychol Soc. 2016 Nov;22(10):968-977.

29.

Cognitive reserve and cortical thickness in preclinical Alzheimer's disease.

Pettigrew C, Soldan A, Zhu Y, Wang MC, Brown T, Miller M, Albert M; BIOCARD Research Team.

Brain Imaging Behav. 2017 Apr;11(2):357-367. doi: 10.1007/s11682-016-9581-y.

30.

Cortical thickness in relation to clinical symptom onset in preclinical AD.

Pettigrew C, Soldan A, Zhu Y, Wang MC, Moghekar A, Brown T, Miller M, Albert M; BIOCARD Research Team.

Neuroimage Clin. 2016 Jun 15;12:116-22. doi: 10.1016/j.nicl.2016.06.010. eCollection 2016.

31.

Blood glucose levels and cortical thinning in cognitively normal, middle-aged adults.

Wennberg AM, Spira AP, Pettigrew C, Soldan A, Zipunnikov V, Rebok GW, Roses AD, Lutz MW, Miller MM, Thambisetty M, Albert MS.

J Neurol Sci. 2016 Jun 15;365:89-95. doi: 10.1016/j.jns.2016.04.017. Epub 2016 Apr 14.

32.

Hypothetical Preclinical Alzheimer Disease Groups and Longitudinal Cognitive Change.

Soldan A, Pettigrew C, Cai Q, Wang MC, Moghekar AR, O'Brien RJ, Selnes OA, Albert MS; BIOCARD Research Team.

JAMA Neurol. 2016 Jun 1;73(6):698-705. doi: 10.1001/jamaneurol.2016.0194.

33.

Relationship between cerebrospinal fluid biomarkers of Alzheimer's disease and cognition in cognitively normal older adults.

Pettigrew C, Soldan A, Moghekar A, Wang MC, Gross AL, O'Brien R, Albert M.

Neuropsychologia. 2015 Nov;78:63-72. doi: 10.1016/j.neuropsychologia.2015.09.024. Epub 2015 Sep 21.

34.

Changes in Aβ biomarkers and associations with APOE genotype in 2 longitudinal cohorts.

Resnick SM, Bilgel M, Moghekar A, An Y, Cai Q, Wang MC, Thambisetty M, Prince JL, Zhou Y, Soldan A, Wong DF, O'Brien RJ, Ferrucci L, Albert MS.

Neurobiol Aging. 2015 Aug;36(8):2333-9. doi: 10.1016/j.neurobiolaging.2015.04.001. Epub 2015 Apr 4.

35.

Graph theoretic analysis of structural connectivity across the spectrum of Alzheimer's disease: The importance of graph creation methods.

Phillips DJ, McGlaughlin A, Ruth D, Jager LR, Soldan A; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage Clin. 2015 Jan 13;7:377-90. doi: 10.1016/j.nicl.2015.01.007. eCollection 2015.

36.

Relationship of medial temporal lobe atrophy, APOE genotype, and cognitive reserve in preclinical Alzheimer's disease.

Soldan A, Pettigrew C, Lu Y, Wang MC, Selnes O, Albert M, Brown T, Ratnanather JT, Younes L, Miller MI; BIOCARD Research Team.

Hum Brain Mapp. 2015 Jul;36(7):2826-41. doi: 10.1002/hbm.22810. Epub 2015 Apr 16.

37.

Cognitive reserve modulates ERPs associated with verbal working memory in healthy younger and older adults.

Speer ME, Soldan A.

Neurobiol Aging. 2015 Mar;36(3):1424-34. doi: 10.1016/j.neurobiolaging.2014.12.025. Epub 2014 Dec 29.

38.

Cognitive changes preceding clinical symptom onset of mild cognitive impairment and relationship to ApoE genotype.

Albert M, Soldan A, Gottesman R, McKhann G, Sacktor N, Farrington L, Grega M, Turner R, Lu Y, Li S, Wang MC, Selnes O.

Curr Alzheimer Res. 2014;11(8):773-84.

39.

Neural correlates of language and non-language visuospatial processing in adolescents with reading disability.

Diehl JJ, Frost SJ, Sherman G, Mencl WE, Kurian A, Molfese P, Landi N, Preston J, Soldan A, Fulbright RK, Rueckl JG, Seidenberg MS, Hoeft F, Pugh KR.

Neuroimage. 2014 Nov 1;101:653-66. doi: 10.1016/j.neuroimage.2014.07.029. Epub 2014 Jul 24.

40.

Inter-laboratory ring trials to evaluate serological methods for dourine diagnosis.

Cauchard J, Soldan A, Madeline A, Johnson P, Büscher P, Petry S.

Vet Parasitol. 2014 Sep 15;205(1-2):70-6. doi: 10.1016/j.vetpar.2014.06.025. Epub 2014 Jun 26.

PMID:
25015543
41.

Relationship of cognitive reserve and APOE status to the emergence of clinical symptoms in preclinical Alzheimer's disease.

Pettigrew C, Soldan A, Li S, Lu Y, Wang MC, Selnes OA, Moghekar A, O'Brien R, Albert M, The Biocard Research Team.

Cogn Neurosci. 2013;4(3-4):136-42. doi: 10.1080/17588928.2013.831820. Epub 2013 Aug 25.

42.

Relationship of cognitive reserve and cerebrospinal fluid biomarkers to the emergence of clinical symptoms in preclinical Alzheimer's disease.

Soldan A, Pettigrew C, Li S, Wang MC, Moghekar A, Selnes OA, Albert M, O'Brien R; BIOCARD Research Team.

Neurobiol Aging. 2013 Dec;34(12):2827-34. doi: 10.1016/j.neurobiolaging.2013.06.017. Epub 2013 Aug 1.

43.

Effect of repetition lag on priming of unfamiliar visual objects in young and older adults.

Gordon LT, Soldan A, Thomas AK, Stern Y.

Psychol Aging. 2013 Mar;28(1):219-31. doi: 10.1037/a0030929. Epub 2012 Dec 31.

44.

Priming and stimulus-response learning in perceptual classification tasks.

Soldan A, Clarke B, Colleran C, Kuras Y.

Memory. 2012;20(4):400-13. doi: 10.1080/09658211.2012.669482. Epub 2012 Mar 22.

PMID:
22436079
45.

Changes to the VLA's diagnostic surveillance service.

Soldan A.

Vet Rec. 2010 Sep 25;167(13):499. doi: 10.1136/vr.c5211. No abstract available.

PMID:
20871087
46.

Neural mechanisms of repetition priming of familiar and globally unfamiliar visual objects.

Soldan A, Habeck C, Gazes Y, Stern Y.

Brain Res. 2010 Jul 9;1343:122-34. doi: 10.1016/j.brainres.2010.04.071. Epub 2010 May 5.

47.

Priming of familiar and unfamiliar visual objects over delays in young and older adults.

Soldan A, Hilton HJ, Cooper LA, Stern Y.

Psychol Aging. 2009 Mar;24(1):93-104. doi: 10.1037/a0014136.

48.

Bias effects in the possible/impossible object decision test with matching objects.

Soldan A, Hilton HJ, Stern Y.

Mem Cognit. 2009 Mar;37(2):235-47. doi: 10.3758/MC.37.2.235.

49.

Effects of dividing attention during encoding on perceptual priming of unfamiliar visual objects.

Soldan A, Mangels JA, Cooper LA.

Memory. 2008 Nov;16(8):873-95. doi: 10.1080/09658210802360595. Epub 2008 Sep 26.

50.

Aging does not affect brain patterns of repetition effects associated with perceptual priming of novel objects.

Soldan A, Gazes Y, Hilton HJ, Stern Y.

J Cogn Neurosci. 2008 Oct;20(10):1762-76. doi: 10.1162/jocn.2008.20130.

Supplemental Content

Loading ...
Support Center